EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Glucocorticoid Receptor: Molecular Mechanism and New Therapeutic Opportunities

Leonard Buckbinder, Ralph P Robinson

Current Drug Target -Inflammation & Allergy · 2002

DOI: 10.2174/1568010023344751 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Drug Target -Inflammation & Allergy, 2002. Verfasst von Leonard Buckbinder und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Inc., Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA. buckbinder@groton.pfizer.com. Die Arbeit wurde bisher 32-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acid SequenceAnimalsAnti-Inflammatory AgentsChromatinDNADrug Delivery SystemsGene ExpressionHumansMolecular Sequence DataReceptors, GlucocorticoidResponse ElementsSteroids

Substanzen

Anti-Inflammatory AgentsChromatinReceptors, GlucocorticoidSteroidsDNA

Autor:innen und Institutionen

  • Pfizer Inc., Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA. buckbinder@groton.pfizer.com

Zitieren

APA

Buckbinder, L., & Robinson, R. P. (2002). The Glucocorticoid Receptor: Molecular Mechanism and New Therapeutic Opportunities. Current Drug Target -Inflammation & Allergy. https://doi.org/10.2174/1568010023344751

Vancouver

Buckbinder L, Robinson RP. The Glucocorticoid Receptor: Molecular Mechanism and New Therapeutic Opportunities. Current Drug Target -Inflammation & Allergy. 2002. doi:10.2174/1568010023344751

BibTeX
@article{Buckbinder2002,
  author = {Buckbinder, Leonard and Robinson, Ralph P},
  title = {The Glucocorticoid Receptor: Molecular Mechanism and New Therapeutic Opportunities},
  journal = {Current Drug Target -Inflammation & Allergy},
  year = {2002},
  doi = {10.2174/1568010023344751}
}
Kostenlos starten →